PROHALO is cutting-edge technology for your business, in order to comply with pharmacovigilance regulations globally. It's easy to setup and use, with many pre-configured best-practice workflows, so you can start using the system straight away. PROHALO is for pharmaceuticals, biotechs, regulatory agencies, institutions and research organizations. The revolutionary technology solution for life sciences: - Out of the box workflows - AI enabled - GxP compliant (with SOPs) - Integrates with Argus & other databases - Running millions of cases currently - 0% carbon emissions PROHALO is a game-changing solution with a unique subscription model, that will revolutionize drug safety (pharmacovigilance) for pharma companies big and small. Its new features will transform the way that companies can manage their PV processes and promises to create a unified ‘Integrated Universe’ that all pharma companies can enjoy, regardless of their size. PROHALO is a significant development for Insife which launched HALOPV in 2018, first with a couple of modules, later on growing into the world’s first fully comprehensive and cohesive PV solution. Managing all multi-vigilance processes from operational to scientific, HALOPV allows companies to add on whichever of the 18 modules that they required specifically for their business, creating a bespoke platform for each customer.
Revolutionizing Pharmacovigilance with Cutting-Edge Technology
Insife is a leading provider of pharmacovigilance solutions, offering a comprehensive platform and expert consulting to help pharmaceutical and biotech companies efficiently navigate drug safety processes. With nearly 100 safety experts worldwide, Insife provides the largest Europe-based pharmacovigilance services and solutions in the industry. The company's flagship product HALOPV is an end-to-end system to manage multivigilance processes from operational to scientific tasks. Insife also offers regulatory intelligence, hosting services, and strategic consulting to deliver outstanding domain expertise across the US, Europe, and Asia. With a commitment to transforming drug safety through innovation, Insife is changing the technology landscape for pharmacovigilance worldwide.
In March 2024, it was announced that Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, had acquired Insife. The acquisition will enable Qinecsa to leverage Insife's expertise in software development and consultancy, to enhance its existing pharmacovigilance services and accelerate further innovation in the field. Together, the companies will continue to lead the industry in advancing patient safety, drug development, and regulatory compliance through AI-driven technologies and cutting-edge solutions.
Revolutionizing Pharmacovigilance with Cutting-Edge Technology
Insife is a leading provider of pharmacovigilance solutions, offering a comprehensive platform and expert consulting to help pharmaceutical and biotech companies efficiently navigate drug safety processes. With nearly 100 safety experts worldwide, Insife provides the largest Europe-based pharmacovigilance services and solutions in the industry. The company's flagship product HALOPV is an end-to-end system to manage multivigilance processes from operational to scientific tasks. Insife also offers regulatory intelligence, hosting services, and strategic consulting to deliver outstanding domain expertise across the US, Europe, and Asia. With a commitment to transforming drug safety through innovation, Insife is changing the technology landscape for pharmacovigilance worldwide.
In March 2024, it was announced that Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, had acquired Insife. The acquisition will enable Qinecsa to leverage Insife's expertise in software development and consultancy, to enhance its existing pharmacovigilance services and accelerate further innovation in the field. Together, the companies will continue to lead the industry in advancing patient safety, drug development, and regulatory compliance through AI-driven technologies and cutting-edge solutions.
Exclusive Member Perk (1)
Products (2/3)
The Global Regulatory Intelligence Club for Pharmacovigilance is a unique offering, consisting of a comprehensive collection of global requirements "rules" that have been collected and analyzed by our pharmacovigilance experts - we "crowd-source" the truth by having the members of the club provide their view-points. Then it is also a networking opportunity, specifically for Pharmacovigilance professionals that are involved in the value-chain of identifying, assessing and implementing requirements. Subscription to the club is easy. And will jolt you forward We have done our best to make it easy. Subscribers receive: Access to all global PV requirement documents and associated actionable rules (currently covering 157 countries) An online PROHALO environment, where these rules can be easily accessed, searched, sorted, filtered, listed and exported. (If your company already has HALOPV or PROHALO, we will load any additional requirements into your current environment for you) Ongoing invitations to networking opportunities in the club as well as continuous dialog with our experts The Global Regulatory Intelligence Club for Pharmacovigilance is a unique combination of technology, multi-sourced intelligence and networking, specifically for Pharmacovigilance professionals that are involved in the value-chain of identifying, assessing and implementing requirements. We would love to tell you more and answer any questions you have, take you through a demo or let you test the system so you can explore yourself. Just email hello@insife.com.
Featured Content (2)
Recommendations (0)
Unlock Recommendations
Add 3 suppliers to your My Suppliers list to unlock recommendations.
Refer-a-Friend (1)
Latest Activities (3)
Contacts (2)
Locations (4/6)
Denmark
384A Gladsaxevej, Søborg, 84 2860, DNK
Croatia
80a Horvatova Ulica, Zagreb, 21 10000, HRV
Germany
15a Subbelrather Straße, Köln, NW 50823, DEU
Switzerland Innovation Park Basel Area on Novartis Campus
Lichtstrasse 35, 4056
Schedule a Meeting